Nova Mentis Life Science Corp., a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders, is pleased to announce that it will present at the H.C. Wainwright Psychedelics Conference on December 6, 2021.
Compound Psilocybin
Visit article
Category Press Release
Country Canada
Companies Featured
Nova MentisNova Mentis is a Canadian listed (CSE, FSE) company that holds two subsidiaries, Nova Mentis Biotech and Pilz BioSciences that investigate psychedelics as medicines for a variety of mental health indicators.